MTAP (methylthioadenosine phosphorylase)

2013-06-01  

Identity

HGNC
LOCATION
9p21.3
LOCUSID
ALIAS
BDMF,DMSFH,DMSMFH,HEL-249,LGMBF,MSAP,c86fus
FUSION GENES

Other Information

Locus ID:

NCBI: 4507
MIM: 156540
HGNC: 7413
Ensembl: ENSG00000099810

Variants:

dbSNP: 4507
ClinVar: 4507
TCGA: ENSG00000099810
COSMIC: MTAP

RNA/Proteins

Gene IDTranscript IDUniprot
ENSG00000099810ENST00000419385F8WES2
ENSG00000099810ENST00000427788A0A2R8Y4K0
ENSG00000099810ENST00000460874B4DUC8
ENSG00000099810ENST00000577563J3KRN1
ENSG00000099810ENST00000580718J3QSB7
ENSG00000099810ENST00000580900Q13126
ENSG00000099810ENST00000644715Q13126
ENSG00000099810ENST00000644715A0A384ME80

Expression (GTEx)

0
5
10
15

Pathways

PathwaySourceExternal ID
Cysteine and methionine metabolismKEGGko00270
Cysteine and methionine metabolismKEGGhsa00270
Metabolic pathwaysKEGGhsa01100
Methionine salvage pathwayKEGGhsa_M00034
Methionine salvage pathwayKEGGM00034
MetabolismREACTOMER-HSA-1430728
Metabolism of amino acids and derivativesREACTOMER-HSA-71291
Metabolism of polyaminesREACTOMER-HSA-351202
Methionine salvage pathwayREACTOMER-HSA-1237112
Sulfur amino acid metabolismREACTOMER-HSA-1614635

References

Pubmed IDYearTitleCitations
386783232024[Methylthioadenosine phosphorylase and p16 as surrogate diagnostic markers for CDKN2A homozygous deletion in brain tumors].0
387817642024Concordance between CDKN2A homozygous deletion and MTAP immunohistochemical loss in fluoroedenite-induced pleural mesothelioma: An immunohistochemical and molecular study on a single-institution series.0
386783232024[Methylthioadenosine phosphorylase and p16 as surrogate diagnostic markers for CDKN2A homozygous deletion in brain tumors].0
387817642024Concordance between CDKN2A homozygous deletion and MTAP immunohistochemical loss in fluoroedenite-induced pleural mesothelioma: An immunohistochemical and molecular study on a single-institution series.0
355122202023BAP1 and Claudin-4, But Not MTAP, Reliably Distinguish Borderline and Low-grade Serous Ovarian Tumors From Peritoneal Mesothelioma.2
361831552023MTAP deficiency contributes to immune landscape remodelling and tumour evasion.1
365503822023Correlation of MTAP immunohistochemical deficiency with CDKN2A homozygous deletion and clinicopathological features in pleomorphic xanthoastrocytoma.1
372774472023MTAP-ANRIL gene fusion promotes melanoma epithelial-mesenchymal transition-like process by activating the JNK and p38 signaling pathways.2
380923712023Methylthioadenosine Phosphorylase and Breast Cancer 1 Protein-Associated Protein 1 as Biomarkers for the Peritoneal Mesothelioma.0
355122202023BAP1 and Claudin-4, But Not MTAP, Reliably Distinguish Borderline and Low-grade Serous Ovarian Tumors From Peritoneal Mesothelioma.2
361831552023MTAP deficiency contributes to immune landscape remodelling and tumour evasion.1
365503822023Correlation of MTAP immunohistochemical deficiency with CDKN2A homozygous deletion and clinicopathological features in pleomorphic xanthoastrocytoma.1
372774472023MTAP-ANRIL gene fusion promotes melanoma epithelial-mesenchymal transition-like process by activating the JNK and p38 signaling pathways.2
380923712023Methylthioadenosine Phosphorylase and Breast Cancer 1 Protein-Associated Protein 1 as Biomarkers for the Peritoneal Mesothelioma.0
344633362022Loss of Methylthioadenosine Phosphorylase by Immunohistochemistry Is Common in Pulmonary Sarcomatoid Carcinoma and Sarcomatoid Mesothelioma.2

Citation

Dessen P

MTAP (methylthioadenosine phosphorylase)

Atlas Genet Cytogenet Oncol Haematol. 2013-06-01

Online version: http://atlasgeneticsoncology.org/gene/53357